Mounting pressure on the U.S. Food and Drug Administration (FDA) to do something about beta-methylphenethylamine, or BMPEA, being widely used in weight loss and energy supplements may have helped spark the agency to recently issue warning letters to several companies demanding that the “super caffeine” products be pulled from the market. FDA WarningBMPEA is closely related to amphetamines. A public health alert in Canada has called the supplement a “serious health risk” and forced at least one recall. In the U.S., however, FDA’s response was called “lethargic” by New York Times editorial writers on April 13. The Times said FDA’s
Continue Reading FDA Warning Letters: Companies Told to Stop Distributing Supplements Containing BMPEA